Real-world treatment persistence of non-tumor necrosis factor inhibitors versus tumor necrosis factor inhibitors among patients with rheumatoid arthritis in South KoreaPark, Jae-A; Lee, Min-Young; Nam, Jin Hyun; Shin, Ju-Young; Wood, Robert; Holbrook, Tim; Kwon, Sun-Hong · Current Medical Research and Opinion · 2019

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitorHubert Marotte; Béatrice Arnaud; Jennifer Diasparra; Saloua Zrioual; Pierre Miossec · 2008

Is treatment with tumor necrosis factor inhibitors safe in pregnant patients?Sammaritano, Lisa R · Nature Clinical Practice Rheumatology · 2007

Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitorsYang Mao-Draayer, Tiyonnoh Cash · 2013

Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory MyopathyLabrador-Horrillo, Moises; Tarres, Miquel · Current Rheumatology Reviews · 2005

Efficacy of Tumor Necrosis Factor Inhibitors in Patients With Ankylosing SpondylitisDülgeroğlu Erdoğdu, Deniz · Archives of Rheumatology · 2014

Prurigo nodularis in a patient with pustular psoriasis, treated with tumor necrosis factor inhibitorsJournal of the American Academy of Dermatology · 2015

Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitorsSolomon, A. J.; Spain, R. I.; Kruer, M. C.; Bourdette, D. · Multiple Sclerosis Journal · 2011